Snowball logo
logo
KG_logo

KING PHARMACEUTICALS INC

KG β€’ NYSE
$5.12+$0.26Β  (5.35%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
98.7258.131.3300223.84734.0547.42
COGS
--3.5252723.4017848.99220.44
Gross Profit
98.7258.13(2.19525)1.84780325.0626.95
Operating Expenses & Income
Operating Income
30.55(49.32)(4.445216)0.14176249.61(35.63)
Total Operating Expenses
--2.2499660.303454(24.55)62.58
R&D Expenses
------
Selling General & Admin Expenses
--1.9749085.10829.0657.32
Earnings from Continuing Operations
Interest Expense
(19.33)(19.33)--(9.865)(16.42)
Interest Income
--0.2298050.21255-2.741
Income Tax Expense
0.015(0.557)-0.030.068(0.133)
Net Income
Net Income
25.62(60.35)(4.215411)(1.291)46.73(38.32)
Supplemental
EBIT
30.55(49.32)(4.445216)(1.261)59.47-
EBITDA
38.24(41.06)(4.445216)0.14176259.56(19.86)
In millions of USD, except % and values per 1 share